Evidence map›Paper›PMID 31931514›Full record

Trial reportPloS one2020

Key barriers and enablers associated with uptake and continuation of oral pre-exposure prophylaxis (PrEP) in the public sector in Zimbabwe: Qualitative perspectives of general population clients at high risk for HIV.

Makaita M Gombe, Brigid E Cakouros, Getrude Ncube, Nonhlanhla Zwangobani, Portia Mareke, Alec Mkwamba, Marta R Prescott, Taurai Bhatasara, Michael Murwira, Alexio Z Mangwiro and 1 more

Open access · goldAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed, 2 pooled it
1.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 2 syntheses or guidelines pooled it, 116 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. medRxiv : the preprint server for health sciences · 2026
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Makaita M GombeDemand Driven Evaluations for Decisions (3DE), Clinton Health Access Initiative, Harare, Zimbabwe.ORCID 0000-0003-0133-3547
Brigid E CakourosDemand Driven Evaluations for Decisions (3DE), Clinton Health Access Initiative, Harare, Zimbabwe.
Getrude NcubeHIV Prevention, Ministry of Health and Child Care, Harare, Zimbabwe.
Nonhlanhla ZwangobaniTechnical Directorate, Zimbabwe National Family Planning Council, Harare, Zimbabwe.
Portia MarekeDemand Driven Evaluations for Decisions (3DE), Clinton Health Access Initiative, Harare, Zimbabwe.
Alec MkwambaDemand Driven Evaluations for Decisions (3DE), Clinton Health Access Initiative, Harare, Zimbabwe.
Marta R PrescottApplied Analytics Team, Clinton Health Access Initiative, Boston, United States of America.
Taurai BhatasaraHIV Prevention, Ministry of Health and Child Care, Harare, Zimbabwe.
Michael MurwiraTechnical Directorate, Zimbabwe National Family Planning Council, Harare, Zimbabwe.
Alexio Z MangwiroDemand Driven Evaluations for Decisions (3DE), Clinton Health Access Initiative, Harare, Zimbabwe.
Margaret L PrustApplied Analytics Team, Clinton Health Access Initiative, Boston, United States of America.
Boston University · USMinistry of Health and Child Welfare · ZWNational AIDS Council · ZW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUnderstanding the perspectives and preferences of clients eligible for pre-exposure prophylaxis (PrEP) is essential to designing programs that meet clients' needs. To date, most PrEP programs in limited-resource settings have been implemented by partner organizations for specific target populations, but the government of Zimbabwe aims to make PrEP available to the broader population at substantial risk in public sector clinics. However, there is limited information on general population perspectives about PrEP in Zimbabwe.

methodsA qualitative study was conducted to explore clients' motivation to take or decline PrEP and continue or discontinue PrEP. Through a PrEP pilot in one urban family planning clinic and one rural youth center in Zimbabwe, 150 HIV-negative clients screened as being at high risk of HIV and were offered PrEP between January and June 2018. Sixty semi-structured interviews were conducted with clients who agreed to follow-up (including 5 decliners, all from the rural youth center, and 55 accepters, with 42 from the rural youth center and 13 from the urban family planning clinic). Interviews were conducted after either the first or second PrEP follow-up appointment or after the client declined PrEP. Interviews were audio recorded, de-identified, transcribed, and coded thematically.

resultsPrEP uptake was driven by risk perception for HIV, and in many cases, that risk was introduced by the unsafe behavior or HIV-positive status of a partner. Among sero-discordant couples (SDCs), the desire to safely conceive a child was also cited as a factor in taking PrEP. Clients who opted for PrEP preferred it to other forms of HIV prevention. SDCs reported decreased condom use after PrEP initiation and in some cases were using PrEP while trying to conceive a child. After initiating PrEP, clients had more confidence in their sexual relationships and less stress associated with negotiating condom use. Family and partner support was critical to starting and continuing PrEP, but some clients stopped PrEP or missed appointments due to side effects or logistical challenges such as transportation.

conclusionsResults of this study can be used to provide operational guidance for national public sector roll-out of PrEP as part of combination HIV prevention in Zimbabwe. Based on feedback and experiences of clients, the training materials for health workers can be refined to ensure that health workers are prepared to counsel clients on the decision to start and/or continue PrEP and answer common client questions. Program advertisements should also be targeted with key messages that speak to client experiences.

trial registrationClinical Trial Registry Number: PACTR201710002651160.

Indexed as

Health Knowledge, Attitudes, PracticePre-Exposure ProphylaxisAdolescentAdultAnti-HIV AgentsFemaleFollow-Up StudiesHealth Services AccessibilityHIV InfectionsHumansInterviews as TopicMaleMedication AdherenceMotivationPilot ProjectsPublic SectorAnti-HIV Agents

Identifiers

PMID31931514
PMCPMC6957335
OpenAlexW2999369432

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.